Author

Shiquan Meng

Observed name: Meng Shiquan

Institutions: Shanghai University, Shanghai Advanced Research Institute, University of Chinese Academy of Sciences

Observed institutions: Shanghai University, Second Military Medical University, Chinese Academy of Sciences, Shanghai Advanced Research Institute, Eastern Hepatobiliary Surgery Hospital, University of Chinese Academy of Sciences

ORCID: 0000-0002-1037-2284

Observed ORCID: 0000-0002-1037-2284

OpenAlex ID: A5006762241

Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy

2019 · Qing Zhao, Bo Zheng, et al. · Biomedicine & Pharmacotherapy · 35

An Efficient and Reliable Assay for Investigating the Effects of Hypoxia/Anoxia on Drosophila

2017 · Yiling Xia, Wangchao Xu, et al. · Neuroscience Bulletin · 14

Degradation of alpha-synuclein by dendritic cell factor 1 delays neurodegeneration and extends lifespan in Drosophila

2018 · Shiqing Zhang, Ruili Feng, et al. · Neurobiology of Aging · 13

SH2B1 is Involved in the Accumulation of Amyloid-β 42 in Alzheimer’s Disease

2016 · Yijun Shen, Yiling Xia, et al. · Journal of Alzheimer s Disease · 13

Hyccin/FAM126A deficiency reduces glial enrichment and axonal sheath, which are rescued by overexpression of a plasma membrane-targeting PI4KIIIα in Drosophila

2021 · Qichao Zhang, Baozhu Zhang, et al. · Biochemical and Biophysical Research Communications · 4

肝細胞癌の進行を抑制するためのslc46a3の発現増加とソラフェニブ療法に対するその効果【jst・京大機械翻訳】

2019 · Zhao Qing, Zheng Bo, et al. · Biomedicine & Pharmacotherapy

Works count: 6

Citation count: 79

H-index: 4

I10-index: 4